Rapid Antibacterial Activity Assessment of Chimeric Lysins
Open Access
- 19 February 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2430
Abstract
Various chimeric lysins have been developed as efficacious antibiotics against multidrug-resistant bacteria, but direct comparisons of their antibacterial activities have been difficult due to the preparation of multiple recombinant chimeric lysins. Previously, we reported an Escherichia coli cell-free expression method to better screen chimeric lysins against Staphylococcus aureus, but we still needed to increase the amounts of expressed proteins enough to be able to detect them non-isotopically for quantity comparisons. In this study, we improved the previous cell-free expression system by adding a previously reported artificial T7 terminator and reversing the different nucleotides between the T7 promoter and start codon to those of the T7 phage. The new method increased the expressed amount of chimeric lysins enough for us to detect them using Western blotting. Therefore, the qualitative comparison of activity between different chimeric lysins has become possible via the adjustment of the number of variables between samples without protein purification. We applied this method to select more active chimeric lysins derived from our previously reported chimeric lysin (ALS2). Finally, we compared the antibacterial activities of our selected chimeric lysins with reported chimeric lysins (ClyC and ClyO) and lysostaphin and determined the rank orders of antibacterial activities on different Staphylococcus aureus strains in our experimental conditions.Keywords
All Related Versions
Funding Information
- GeNiner Inc. (GN202301)
This publication has 51 references indexed in Scilit:
- MPEPE, a predictive approach to improve protein expression in E. coli based on deep learningComputational and Structural Biotechnology Journal, 2022
- Construction and characterization of a chimeric lysin ClyV with improved bactericidal activity against Streptococcus agalactiae in vitro and in vivoApplied Microbiology and Biotechnology, 2020
- Evolution of a major bovine mastitic genotype (rpoB sequence type 10-2) of Staphylococcus aureus in cowsJournal of Microbiology, 2019
- (Ph)ighting Phages: How Bacteria Resist Their ParasitesCell Host & Microbe, 2019
- Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activityApplied Microbiology and Biotechnology, 2015
- Linkers in the structural biology of protein–protein interactionsProtein Science, 2013
- Methicillin Resistant S. aureus in Human and Bovine MastitisJournal of Mammary Gland Biology and Neoplasia, 2011
- Bacteriophage endolysins — current state of research and applicationsCurrent Opinion in Microbiology, 2005
- Bacteriophage therapy: a revitalized therapy against bacterial infectious diseasesJournal of Infection and Chemotherapy, 2005
- Analyzing and enhancing mRNA translational efficiency in an Escherichia coli in vitro expression systemBiochemical and Biophysical Research Communications, 2004